about
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED);...
Read More
19.42
0.19
(0.99%)
159.9K
XNAS Volume
XNAS 10 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Oculis Holding AG is on 12 Nov 2025 for the purpose of Stifel Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Oculis Holding AG Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..